DEXIS
By Dental Imaging Technologies Corporation
DEXIS, part of Envista Holdings, is a global leader in dental imaging, offering 2D/3D X-ray sensors, intraoral scanners, CBCT units, and integrated diagnostic software under the DTX Studio™ Clinic platform. Its ecosystem powers over 150,000 devices in 50+ countries with a workforce of ~1,000 globally
2D Sensors: DEXIS Platinum, Titanium, Ti2—ergonomic designs, low-dose imaging, AI-enabled detection of six dental findings.
3D Imaging: ORTHOPANTOMOGRAPH™ OP 3D LX/EX, i‑CAT CBCT scanners.
Intraoral Scanning: IS 3700/3800/3800W with ScanFlow guided scan software.
Imaging Software: DEXIS Imaging Suite & DTX Studio Clinic unify imaging workflows across modalities, integrate with sensors, scanners, and CBCT. Includes AI‑driven diagnostic tools like DEXassist.
Digital ecosystem launch (Feb 2024): Seamless workflow from diagnosis to delivery, across CBCT, scanning, and planning
Ti2 Sensor (May 2024): Enhanced durability and AI-based detection of six dental issues
Connect Pro (Aug 2024): IoT-based device monitoring and proactive support
OP 3D EX launch (Sept 2024): New CBCT unit paired with DTX enhancements for chairside implant planning
Innovation-driven ethos, anchored in 60+ years of imaging heritage and over 500 patents, DEXIS.
Global reach: Over 150,000 installed devices and ~100,000+ clinicians using DTX Studio
Sectors: General dentistry, orthodontics, oral surgery, and labs worldwide.
